INS and metabolic syndrome: Pioglitazone also preserves beta-cell function and improves the metabolic syndrome through several functions, i.e., by enhancing insulin sensitivity, lowering blood pressure, reducing triglycerides and increasing high-density lipoprotein (HDL) (reviewed in DeFronzo et al. [23]).